Circulating tumour DNA (ctDNA) is a potential biomarker that could contribute to more
judicious patient selection for personalised treatment. This review and meta-analysis gives …

Simple Summary Liver metastases occur in almost half of patients with colorectal cancer,
either at the time of presentation (synchronous) or eventually as a metachronous recurrence …

Importance Although treatment and prognosis of synchronous liver metastases from
colorectal cancer are relatively well known, a comparative description of the incidence …

Background The histopathological growth patterns (HGPs) are a prognostic and predictive
biomarker in colorectal cancer liver metastasis (CRLM). This study evaluates the …

Simple Summary Colorectal cancer remains one of the most significant sources of cancer-
related morbidity and mortality worldwide. The liver is the most common site of metastatic …

Background: Although the global prevalence of colorectal cancer (CRC) is decreasing, there
has been an increase in incidence among young-onset individuals, in whom the disease is …

The histopathological growth patterns (HGPs) of liver metastases (LMs) are independently
associated with the long-term prognosis of the primary tumor, with different HGPs predicting …

Background Patients with a 5‐year recurrence‐free survival post liver resection for colorectal
cancer liver metastases (CRLM) are considered to be potentially cured. However, there is a …

Purpose This study aimed to explore the prognostic significance of clinicopathological
characteristics in early-onset versus late-onset colorectal liver metastases (CRLM). Methods …

Transplantation for non-resectable colorectal liver metastasis (CRLM) has become accepted
for a few, select patients following stringent criteria. With improved understanding of the …